>
August 09 2020

EZETIMIBE

List of brands containing ezetimibe   

This page contains list of brands of authorized pharmaceutical specialties of the active principle ezetimibe in the countries listed below:

Australia] [ Brazil] [ Canada] [ France] [ Germany] [ India] [ Italy] [ Japan] [ Mexico] [ Pakistan] [ Puerto Rico] [ Spain] [ Turkey] [ United Kingdom] [ U.S.A]

Given the nature of the pharmaceutical market, some specialties may be unavailable, have been removed from pharmaceutical market or have changed its name. So that, in no case can take decisions based on the information contained in the page. MEDIZZINE is not responsible for any damage arising from the information provided, which may be incomplete or outdated.

Indications and usage     

The active ingredient ezetimibe belongs to a group of medicines called lipid-lowering which exerts its action by reducing cholesterol absorption in the small intestine.

Ezetimibe is indicated, jointly to diet, in the treatment of diseases characterized by the increase of cholesterol and other blood fats, such as primary hypercholesterolemia, homozygous familial hypercholesterolemia, and sitosterolaemia. Usually, ezetimibe is administered together with other drugs called statins.

Medizzine recommends consult your doctor if you are unsure why has prescribed ezetimibe.

Other ingredients of available commercial presentations:

Each tablet contains 10 mg ezetimibe. Excipients are croscarmellose sodium, lactose monohydrate, magnesium stearate, microcrystalline cellulose, povidone and sodium lauryl sulfate.

Warning:

The composition of the various presentations may vary from one country to another. We recommend you consult the information provided by your local supplier.

Important information     

This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, contact him before taking it.

Before taking the drug     

Do not use ezetimibe

If you are allergic (hypersensitive) to ezetimibe or any of the other ingredients of the medicinal product prescribed to you. If you think may be allergic, ask your doctor.

Allergy symptoms may include:

- Asthma attacks with shortness of breath, audible wheezing or rapid breathing.
- More or less sudden swelling of the face, lips, tongue or elsewhere in the body. It is especially critical if it affects the vocal cords.
- Hives, itching, rash
- Anaphylactic shock (loss of consciousness, paleness, sweating, etc.).

Nor you should take this medicine:

If you have an active liver disease, are pregnant or breastfeeding, you should not take it with a statin.

Take special care with ezetimibe

If you take ezetimibe with a statin, your doctor will perform liver tests (transaminases) to assess the liver state before starting treatment.

If you have moderate or severe hepatic impairment, it is not recommended to take ezetimibe

Taking other medicines

Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including herbal products or drugs obtained without a prescription.

Certain medicines can interact with ezetimibe. In these cases, it may be necessary to change the dose or stop taking any medications.

It is important to tell your doctor if you take any of these drugs:

- Cyclosporine (drug belonging to the group called immunosuppressants that reduce the action of the immune system on the body's defense system against foreign agents), since both ezetimibe and cyclosporine levels in the blood can increase when the two drugs are taken together.
- Warfarin, fluindione or another coumarin anticoagulant (medicine to prevent blood clots).
- Cholestyramine (medicine to treat high blood cholesterol) as it decreases the absorption of ezetimibe, which may decrease the effectiveness of this.
- Fibrates (medicines to treat high cholesterol levels) because they may increase the blood ezetimibe levels.
- Antacids (medicines for treating heartburn and other gastric disorders), since they reduce ezetimibe absorption.

Use with food and beverages

Ezetimibe can be taken with or without food.

Consult your doctor or pharmacist before taking any medicine.

Special physiological situations

Pregnancy and lactation

Always consult your doctor or pharmacist before taking any medicine during pregnancy or lactation.

The use of this medicine is not recommended during pregnancy. It is also not recommended its use during breastfeeding. If necessary, your doctor will decide whether you should using this medicine.

Children

Ezetimibe is not recommended for children under 10 years because there is not enough experience available.

Driving and using machines

This medicine does not affect your ability to drive or operate machinery.

How to use ezetimibe     

Follow carefully the instructions of use of ezetimibe provided by your doctor. Consult your doctor or pharmacist when in doubt. Follow the instructions of the physician in preference to those given on this website, which may be different. Ask your doctor to explain any aspect that you do not understand, contained in the instruction leaflet that comes with the medicine.

Your doctor will determine the appropriate dose and treatment duration; Do not stop taking before your doctor tells, nor prolong its use more than indicated.

Ezetimibe should be taken with other medicines to lower cholesterol (statins) unless your doctor tells you otherwise. You must also continue a diet addressed to reduce cholesterol.

Usual adult dose: 10 mg ezetimibe once daily. This medicine should not be used in children.

Ezetimibe can be taken with or without food and at the most convenient time of day.

If your doctor has prescribed ezetimibe with statins, both medicines can be taken at the same time. In this case, read carefully the statin instructions .

If your doctor has prescribed ezetimibe together with a bile acid sequestrant (as cholestyramine), ezetimibe should be taken at least 2 hours before or 4 hours after taking the bile acid sequestrant.

If you think the effect of the medicine is too strong or too weak, consult your doctor.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

While you take ezetimibe     

If a doctor prescribes another medicine, tell you are taking ezetimibe.

Check with your doctor regularly developments of disorder that motivates the use of ezetimibe. Maybe there is some reason that prevented you properly receive the indicated doses and induce your doctor to erroneous conclusions about treatment.

Do not restart treatment with ezetimibe at your own risk without first talking to your doctor, nor encourage its use by another person, even if have the same symptoms you have. Nor is it advisable to interrupt or reduce the dose without considering the opinion of your doctor.

If you feel unwell during treatment with ezetimibe, immediately consult your doctor.

If you take more than you should:

If you take more ezetimibe than you should, tell your doctor or go to the nearest hospital casualty department straight away. Take the medicine pack with you, even if it is empty.

If you forget to take ezetimibe

If you miss a dose, simply resume your treatment, as usual, the next day. Do not take a double dose to make up for missed doses.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

Side Effects of ezetimibe     

Like all medicines, ezetimibe can cause side effects, although not everybody gets them.

The frequency of side effects is classified into:

Very common: affect 1 out of 1-10 patients
Common: affect 1 out of 10-100 patients
Uncommon: affect 1 out of 100-1.000 patients
Rare: affect 1 out of 1.000-10.000 patients
Very Rare: affect less than 1 in 10,000 patients
Incidence not known: Can not be established the true incidence from the available data

Your doctor has a complete list of these effects. Tell your doctor promptly about these symptoms or any other unusual.

Common side effects:

1. When used alone:

Neurologic disorders: Headaches.

Digestive disorders: Abdominal pain and diarrhea.

2. When used jointly statins:

Neurologic disorders: Headaches, tiredness.

Digestive disorders: Abdominal pain, constipation, diarrhea, flatulence, nausea.

Musculoskeletal disorders: Muscular pain.

Laboratory tests: Increase of some liver function tests (transaminases).

Rare side effects:

Blood and lymphatic disorders:

Decrease in the number of platelets (thrombocytopenia rarely).

Immunologic disorders:

Allergic reactions (which may require treatment right away) including rash (rarely), urticaria (rarely), and angioedema (swelling of the face, lips, tongue and/or throat that may cause difficulty in breathing or swallowing (very rarely).

Digestive disorders:

Nausea (rarely); inflammation of the pancreas (very rarely).

Musculoskeletal disorders:

Joint pain (rarely); muscle pain (rarely).

Hepatobiliary disorders:

Liver disorders (rarely); gallstones (very rarely) and inflammation of the gallbladder (very rarely).

Laboratory tests:

The Increase of some liver function tests (rarely); elevated blood levels of an enzyme derived from muscle (CPK, rarely).

Contact your doctor promptly if you experience pain, tenderness or unexplained muscle weakness while taking ezetimibe.

This is because, in rare cases, this medication can cause serious muscle problems, including muscle breakdown which causes kidney damage, so it may be necessary to withdraw treatment.

This list does not include all adverse reactions associated with the use of ezetimibe, both well established as those that are under consideration or confirmation. In case you feel unwell, should immediately consult with the doctor who prescribed this medicine.

If you notice any side effects not listed in this website or in the leaflet accompanying the package, ask your doctor or pharmacist.

If any of the side effects gets serious, tell your doctor or pharmacist.

List of brands containing ezetimibe     

This page contains a list of brands of authorized pharmaceutical specialties of the active principle ezetimibe in the countries listed below:

Australia] [ Brazil] [ Canada] [ France] [ Germany] [ India] [ Italy] [ Japan] [ Mexico] [ Pakistan] [ Puerto Rico] [ Spain] [ Turkey] [ United Kingdom] [ U.S.A]

Given the nature of the pharmaceutical market, some specialties may be unavailable, have been removed from the pharmaceutical market or have changed its name. So that, in no case can take decisions based on the information contained in the page. MEDIZZINE is not responsible for any damage arising from the information provided, which may be incomplete or outdated.

Warning:

With exceptions expressly indicated, these lists do not include active principle associations with other drugs or clinical use containers.

Australia:     

EZETROL 10 mg, tablets

Brazil:     

EZETROL 10 mg, 10, 20 & 30 tablets
ZETIA 10 mg, 10 & 30 tablets

Canada:     

EZETROL 10 mg, 30 & 100 tablets

France:     

EZETIMIBE MSD 10 mg, tablets
EZETROL 10 mg, tablets

Germany:     

EZETROL 10 mg, tablets

India:     

EZEDOC 10 mg, tablets
EZEE 10 mg, tablets
EZENTIA 10 mg, tablets
EZEREM 10 mg, tablets
EZETIB 10 mg, tablets
EZIBLOC 10 mg, tablets
EZTA 10 mg, tablets
EZZICAD 10 mg, tablets
LIPEZET 10 mg, tablets
MIBE 10 mg, tablets
ZETICA 1 mg, tablets

Italy:     

ABSORCOL 10 mg, tablets
EMETIB 10 mg, tablets
EZETROL 10 mg, tablets
ZETIA 10 mg, tablets

Japan:     

ZETIA 10 mg, tablets

Mexico:     

EZETROL 10 mg, 10 & 20 tablets
ZIENT 10 mg, 7, 10, 14, 21, 28, 30 & 60 tablets

Pakistan:     

EMEB 10 mg, tablets
EZEBRIX 10 mg, tablets
EZEMIBE CONSOLIDATED CHEMICAL 10 mg, tablets
EZITA 10 mg, tablets
GELITA 10 mg, tablets
MIEK 10 mg, tablets
ZEMITRA 10 mg, tablets
ZETAB 10 mg, tablets

Spain:     

ADACAI 10 mg, 28 & 100 tablets
EZETROL 10 mg, 28 & 100 tablets

Turkey:     

COLEBYN 10 mg, tablets
EZETEC 10 mg, tablets
EZETROL 10 mg, tablets
KOLEZ 10 mg, tablets

United Kingdom:     

EZETROL 10 mg, tablets

U.S.A. and Puerto Rico:     

ZETIA 10 mg, 30 & 90 tablets

Page updated: December 13, 2010.